CD8A and gastric cancer: CD8+ T cells in gastric cancer organoid cultures without PMN-MDSCs exhibited a significant (* p < 0.05) rise in CTL proliferation due to Nivolumab or Mubritinib (Conditions 2 and 3 respectively, Figure 4f,g).